Bailard »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Bailard

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Bailard

Quarter filed Position value Share count Share price at filing
2025-09-30 $227k 5.9k 38.83

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Calif Mun Bd Etf (CMF)
Gilead Sciences (GILD)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)

View all positions for Bailard

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Rubric Capital Management
Vanguard Group
Baker Bros. Advisors
Tang Capital Management
Fairmount Funds Management
Acadian Asset Management
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Millennium Management
Pictet Asset Management Holding SA
FMR
Connor, Clark & Lunn Investment Management
Qube Research & Technologies
Parkman Healthcare Partners
Driehaus Capital Management

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A